cabotegravir (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

AdultPediatric

HIV Infection

Pending FDA approval for treatment of HIV (in combination with rilpivirine) for adults whose viral load is suppressed and who are not resistant to cabotegravir or rilpivirine

Safety and efficacy not established

Next:

Pharmacology

Mechanism of Action

HIV-1 integrase strand transfer inhibitor (INSTI)

Cabotegravir, an analog of dolutegravir, prevents viral DNA integration into the host genome and inhibits HIV replication

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.